ImmunityBio, Inc. (IBRX) — Dilution Risk Analysis
Current Snapshot
ImmunityBio, Inc. (IBRX) has a DilutionWatch score of 34/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 34/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: SC 13D/A 1, 4 8, XBRL 1.
| Form | Filed | Accession |
|---|---|---|
| SC 13D/A | 2026-08-06 | 0001193125-26-338651 |
| 4 | 2026-07-06 | 0001849739-26-000014 |
| 4 | 2026-07-06 | 0001529371-26-000008 |
| 4 | 2026-07-01 | 0001849739-26-000011 |
| xbrl | 2026-06-30 | xbrl-1641-xbrl_warrant |
| 4 | 2026-06-26 | 0001647994-26-000011 |
| 4 | 2026-06-10 | 0001849739-26-000007 |
| 4 | 2026-06-10 | 0001529371-26-000003 |
| 4 | 2026-06-10 | 0001349193-26-000003 |
| 4 | 2026-06-10 | 0001822674-26-000003 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 12 months | Source |
| Three-year share count growth | 58.73% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 34/10) Source
- Cash Runway
- 12 months Source
- Share Count Growth (3-Year)
- 58.73% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.